00279K.KS
AMOREPACIFIC Group [00279K.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
00279K.KS Stock Summary
Top 10 Correlated ETFs
00279K.KS
Top 10 Correlated Stocks
00279K.KS
In the News
00279K.KS Financial details
Company Rating
Neutral
Market Cap
2209.18B
Income
119.3B
Revenue
4021.34B
Book val./share
39900.61
Cash/share
22526.49
Dividend
667
Dividend %
3.62%
Employees
94
Optionable
No
Shortable
Yes
Earnings
-
P/E
20.55
Forward P/E
-
PEG
2.25
P/S
0.49
P/B
0.51
P/C
0.91
P/FCF
7.77
Quick Ratio
1.44
Current Ratio
3.14
Debt / Equity
0.1
LT Debt / Equity
-
-
-
EPS (TTM)
1.44K
EPS next Y
-
EPS next Q
-
EPS this Y
91.68%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-2.21%
Revenue last 5Y
-8.54%
Revenue Q/Q
5.67%
EPS Q/Q
-27.53%
-
-
-
-
SMA20
5.96%
SMA50
8.21%
SMA100
2.8%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.03%
Gross Margin
71%
Oper. Margin
5%
Profit Margin
2%
Payout
87%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
16830.0-29550.0
52W High
-30.8%
52W Low
+21.51%
RSI
64
Rel Volume
1.45
Avg Volume
6.61K
Volume
9.61K
Perf Week
3.54%
Perf Month
10.48%
Perf Quarter
19.31%
Perf Half Y
15.15%
-
-
-
-
Beta
1.114
-
-
Volatility
481.54%, 626.93%
Prev Close
2.3%
Price
20450
Change
3.91%
00279K.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 75.87K | 59.66K | 64.46K | 54.4K | 48.66K | |
| Net income per share | 1.61K | 125.64 | 2.18K | 753.17 | 1.44K | |
| Operating cash flow per share | 10.03K | 8.07K | 9.24K | 2.23K | 4.72K | |
| Free cash flow per share | 6.26K | 5.3K | 7.65K | 287.1 | 1.92K | |
| Cash per share | 21.97K | 22.07K | 24.82K | 20.21K | 22.7K | |
| Book value per share | 40.65K | 39.33K | 40.02K | 40.62K | 40.22K | |
| Tangible book value per share | 69.31K | 67.2K | 69.86K | 68.7K | 71.77K | |
| Share holders equity per share | 40.65K | 39.33K | 40.02K | 40.62K | 40.22K | |
| Interest debt per share | 5.75K | 5.61K | 4.63K | 3.95K | 4.2K | |
| Market cap | 4522.48B | 2958.17B | 2768.12B | 2293.09B | 1543.69B | |
| Enterprise value | 3919.01B | 2361.39B | 2376.86B | 2010.24B | 1288.85B | |
| P/E ratio | 33.82 | 284.95 | 15.38 | 36.84 | 12.94 | |
| Price to sales ratio | 0.72 | 0.6 | 0.52 | 0.51 | 0.38 | |
| POCF ratio | 5.44 | 4.43 | 3.63 | 12.46 | 3.95 | |
| PFCF ratio | 8.72 | 6.75 | 4.38 | 96.65 | 9.72 | |
| P/B Ratio | 1.34 | 0.91 | 0.84 | 0.68 | 0.46 | |
| PTB ratio | 1.34 | 0.91 | 0.84 | 0.68 | 0.46 | |
| EV to sales | 0.62 | 0.48 | 0.45 | 0.45 | 0.32 | |
| Enterprise value over EBITDA | 3.64 | 3.45 | 3.08 | 3.38 | 3.13 | |
| EV to operating cash flow | 4.72 | 3.54 | 3.11 | 10.92 | 3.3 | |
| EV to free cash flow | 7.55 | 5.39 | 3.76 | 84.73 | 8.12 | |
| Earnings yield | 0.03 | 0 | 0.07 | 0.03 | 0.08 | |
| Free cash flow yield | 0.11 | 0.15 | 0.23 | 0.01 | 0.1 | |
| Debt to equity | 0.13 | 0.14 | 0.11 | 0.09 | 0.1 | |
| Debt to assets | 0.05 | 0.06 | 0.05 | 0.04 | 0.04 | |
| Net debt to EBITDA | -0.56 | -0.87 | -0.51 | -0.48 | -0.62 | |
| Current ratio | 2.37 | 2.44 | 2.37 | 3.01 | 3.21 | |
| Interest coverage | 18.87 | 6.58 | 24.87 | 18.63 | 9.13 | |
| Income quality | 6.21 | 64.25 | 4.24 | 2.96 | 3.27 | |
| Dividend Yield | 0.02 | 0.03 | 0.02 | 0.05 | 0.03 | |
| Payout ratio | 0.76 | 7.55 | 0.34 | 1.69 | 0.45 | |
| Sales general and administrative to revenue | 0.16 | 0.19 | 0.18 | 0.19 | 0 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Intangibles to total assets | 0.09 | 0.09 | 0.09 | 0.11 | 0.08 | |
| Capex to operating cash flow | -0.38 | -0.34 | -0.17 | -0.87 | -0.59 | |
| Capex to revenue | -0.05 | -0.05 | -0.02 | -0.04 | -0.06 | |
| Capex to depreciation | -0.54 | -0.43 | -0.32 | -0.5 | -0.89 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 38.43K | 10.54K | 44.29K | 26.24K | 36.14K | |
| ROIC | 0.08 | 0.03 | 0.06 | 0.04 | 0.03 | |
| Return on tangible assets | 0.02 | 0 | 0.02 | 0.01 | 0.02 | |
| Graham Net | 7.26K | 9.89K | 12.47K | 12.85K | 15.43K | |
| Working capital | 1680.03B | 1682.9B | 1742.19B | 1714.48B | 1894.04B | |
| Tangible asset value | 5740.72B | 5552.41B | 5772.19B | 5677.13B | 5930.86B | |
| Net current asset value | 1104.66B | 1336.36B | 1452.95B | 1448.88B | 1643.95B | |
| Invested capital | 0.13 | 0.14 | 0.11 | 0.09 | 0.1 | |
| Average receivables | 367.69B | 394.36B | 361.14B | 366.47B | 368.78B | |
| Average payables | 96.79B | 89.54B | 84.89B | 76.55B | 60.36B | |
| Average inventory | 511.41B | 501.5B | 510.63B | 501.39B | 461.4B | |
| Days sales outstanding | 24.77 | 26.82 | 24.67 | 30.28 | 33.1 | |
| Days payables outstanding | 18.09 | 15 | 19.5 | 13.27 | 17.09 | |
| Days of inventory on hand | 90.57 | 96.61 | 110.83 | 105.89 | 125.35 | |
| Receivables turnover | 14.74 | 13.61 | 14.79 | 12.05 | 11.03 | |
| Payables turnover | 20.18 | 24.33 | 18.72 | 27.51 | 21.36 | |
| Inventory turnover | 4.03 | 3.78 | 3.29 | 3.45 | 2.91 | |
| ROE | 0.04 | 0 | 0.05 | 0.02 | 0.04 | |
| Capex per share | -3.77K | -2.77K | -1.59K | -1.94K | -2.8K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 14.33K | 12.21K | 12.47K | 11.66K | 12.22K | |
| Net income per share | -68.77 | 646.51 | 272.29 | 303.32 | 219.81 | |
| Operating cash flow per share | 2.37K | 1.55K | 1.87K | -466.76 | 1.75K | |
| Free cash flow per share | 1.75K | 849.22 | 1.18K | -1.09K | 969.96 | |
| Cash per share | 20.21K | 21.87K | 22.13K | 20.32K | 22.53K | |
| Book value per share | 40.62K | 40.82K | 40.29K | 40.44K | 39.9K | |
| Tangible book value per share | 68.7K | 69.29K | 68.78K | 68.67K | 71.21K | |
| Share holders equity per share | 40.62K | 40.82K | 40.29K | 40.44K | 39.9K | |
| Interest debt per share | 3.92K | 4.02K | 3.85K | 3.94K | 4.05K | |
| Market cap | 2293.15B | 2326.24B | 1646.98B | 1694.14B | 1555.86B | |
| Enterprise value | 2010.3B | 1718.26B | 1076.54B | 1234.81B | 1301.01B | |
| P/E ratio | -100.88 | 10.89 | 18.3 | 16.9 | 21.25 | |
| Price to sales ratio | 1.94 | 2.31 | 1.6 | 1.76 | 1.53 | |
| POCF ratio | 11.69 | 18.16 | 10.63 | -43.92 | 10.66 | |
| PFCF ratio | 15.88 | 33.15 | 16.86 | -18.85 | 19.26 | |
| P/B Ratio | 0.68 | 0.69 | 0.49 | 0.51 | 0.47 | |
| PTB ratio | 0.68 | 0.69 | 0.49 | 0.51 | 0.47 | |
| EV to sales | 1.7 | 1.7 | 1.04 | 1.28 | 1.28 | |
| Enterprise value over EBITDA | 12.78 | 11.63 | 14.07 | 13.33 | 13.81 | |
| EV to operating cash flow | 10.25 | 13.41 | 6.95 | -32.01 | 8.91 | |
| EV to free cash flow | 13.92 | 24.48 | 11.02 | -13.74 | 16.1 | |
| Earnings yield | 0 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0.06 | 0.03 | 0.06 | -0.05 | 0.05 | |
| Debt to equity | 0.09 | 0.1 | 0.09 | 0.1 | 0.1 | |
| Debt to assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Net debt to EBITDA | -1.8 | -4.11 | -7.46 | -4.96 | -2.7 | |
| Current ratio | 3.01 | 2.97 | 3.06 | 3.15 | 3.21 | |
| Interest coverage | 6.2 | 12.09 | 2.52 | 4.36 | 4.44 | |
| Income quality | -34.52 | 2.4 | 6.88 | -1.54 | 7.97 | |
| Dividend Yield | 0.01 | 0 | 0.03 | 0 | 0 | |
| Payout ratio | -3.21 | 0 | 2.39 | 0 | 0 | |
| Sales general and administrative to revenue | 0.18 | 0.2 | 0.2 | 0.23 | 0 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.11 | 0.11 | 0.11 | 0.11 | 0.08 | |
| Capex to operating cash flow | -0.26 | -0.45 | -0.37 | 1.33 | -0.45 | |
| Capex to revenue | -0.04 | -0.06 | -0.06 | -0.05 | -0.06 | |
| Capex to depreciation | -0.66 | -0.88 | -0.88 | -0.8 | -1.01 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 7.93K | 24.37K | 15.71K | 16.61K | 14.05K | |
| ROIC | 0 | 0.02 | 0 | 0.01 | 0 | |
| Return on tangible assets | 0 | 0.01 | 0 | 0 | 0 | |
| Graham Net | 12.85K | 13.99K | 14.61K | 13.98K | 15.31K | |
| Working capital | 1714.48B | 1786.06B | 1814.2B | 1793.23B | 1894.04B | |
| Tangible asset value | 5677.13B | 5725.64B | 5683.96B | 5674.76B | 5930.86B | |
| Net current asset value | 1448.88B | 1528.8B | 1573.22B | 1553.54B | 1643.95B | |
| Invested capital | 0.09 | 0.1 | 0.09 | 0.1 | 0.1 | |
| Average receivables | 407.38B | 380.43B | 389.91B | 418.83B | 405.23B | |
| Average payables | 74.55B | 66.48B | 74.52B | 64.98B | 59.67B | |
| Average inventory | 498.7B | 450.42B | 428.76B | 424.45B | 447.55B | |
| Days sales outstanding | 28.35 | 34.6 | 34.21 | 41.65 | 32.24 | |
| Days payables outstanding | 12.98 | 19.15 | 19.23 | 16.02 | 17.08 | |
| Days of inventory on hand | 103.59 | 112.06 | 108.68 | 123.09 | 125.29 | |
| Receivables turnover | 3.17 | 2.6 | 2.63 | 2.16 | 2.79 | |
| Payables turnover | 6.93 | 4.7 | 4.68 | 5.62 | 5.27 | |
| Inventory turnover | 0.87 | 0.8 | 0.83 | 0.73 | 0.72 | |
| ROE | 0 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Capex per share | -626.5 | -701.07 | -691.76 | -620.94 | -782.66 |
00279K.KS Frequently Asked Questions
What is AMOREPACIFIC Group stock symbol ?
AMOREPACIFIC Group is a KR stock and trading under the symbol 00279K.KS
What is AMOREPACIFIC Group stock quote today ?
AMOREPACIFIC Group stock price is $20450 today.
Is AMOREPACIFIC Group stock public?
Yes, AMOREPACIFIC Group is a publicly traded company.
Company Profile
- Volume Average 6.61K
- Market Capitalization 2209.18B
- Employee 94
- CEO Mr. Kyungbae Suh
- Headquarters Seoul,KR
- IPO Date 2019-12-26
-
Website
https://www.apgroup.com 
AMOREPACIFIC Group, through its subsidiaries, manufactures, markets, and trades in cosmetics, personal care goods, and related products in Korea, Asia, North America, and internationally. The company offers cosmetics, perfumes, medical beauty products, beauty devices, inner beauty products, hair and body care products, dental care, and tea culture products under the AMORE pacific, Sulwhasoo, LANEIGE, Mamonde, Innisfree, ETUDE, SIENU, HERA, HOLITUAL, primera, IOPE, HANYUL, LIRIKOS, OUTRUN, EASY PEASY, Espoir, RAREKIND, STEADY, SOON+, ODYSSEY, MIREPA, BRO&TIPS!, BE READY, enuf proj, GOUTAL, fradore, AESTURA, makeON, VITAl BEAUTIE, cubeme, Ryo, mise en scene, Fresh Pop, LABO-H, Ayunche, amos, HAPPY BATH, illiyoon, FILLVOID, MEDIAN, Boncho Study, Pleasia, and OSULLOC brands. It is also involved in manufacturing and marketing of medicines, glass, green tea, detergents, and organic compounds; manufacturing, printing, and marketing of paper containers; packaging of products; manufacturing of industrial machinery; and managing of facilities. The company was formerly known as PACIFIC Corporation and changed its name to AMOREPACIFIC Group in March 2011. AMOREPACIFIC Group was founded in 1945 and is headquartered in Seoul, South Korea.
